Limin Group announced that on December 19, 2024, it signed a "Global Strategy cooperation agreement" with Chengdu Green The Cigna Group Biotechnology Co., Ltd. Both parties will focus on new small peptide biopesticides based on the AI + synthetic biology manufacturing platform, utilizing small peptide mining, molecular modification, and synthetic biology technology as underlying technologies, and jointly develop, promote, and apply new agricultural small peptide biological products. This cooperation is an important initiative in the company's "synthetic biology" strategy, aiming to enrich the company's product structure and enhance core competitiveness. The agreement does not specify the exact amount and implementation schedule; further cooperation details will be determined through signed contracts or agreements.